Visiting BioVectra
February 8, 2019
That’s Nice is pleased to be visiting the team at BioVectra this week, even if it means traversing the winter tundra of Prince Edward Island to get there.
Globyz Pharma in PA
February 8, 2019
We are pleased to support Globyz Pharma with strategic content development and placement in the Q1 Edition of Pharma’s Almanac.
Supporting TSRL
February 8, 2019
That’s Nice is proud to support TSRL, an incubator company based in Michigan. TSRL’s mission is to advance promising therapeutics for treating severe and multi-drug resistant infections.
Talking Innovation with Therapure
February 7, 2019
We caught up with Therapure Biopharma CEO Nick Green during our extended trip to Toronto this week. The Therapure business has evolved as innovative drug development for rare disease opportunities are on the rise.
Connecting with Dalton Pharma
February 7, 2019
It was a pleasure to reconnect with Peter Pekos, Founder and Chairman of Toronto-based Dalton Pharma Services.
Visiting Globyz Pharma
February 7, 2019
It was a pleasure to meet Globyz Pharma CEO Salman Pathan, who has a growing supply chain logistics company just outside Toronto.
Eastman Continues to Thrive
February 5, 2019
Eastman Chemical Company, one of our original specialty chemical customers from 2000/2001, is still going strong. Pictured here is Eastman’s corporate headquarters in Kingsport, Tennessee, captured during a recent visit to the Volunteer State.
CAI Strives for Excellence
January 24, 2019
We are proud to support Commissioning Agents Inc in the upcoming Q1 issue of Pharma’s Almanac.
Highlighting 21159 Pharma
January 24, 2019
We proudly support Steve King and 21159 Pharma in the upcoming Q1 issue of Pharma’s Almanac.
Stellar Management at PharmaBioSource
January 24, 2019
Pharma’s Almanac is excited to support and feature PharmaBioSource’s management team in our Q1 issue.
Dalton Still Growing Strong
January 24, 2019
Pharma’s Almanac is proud to support the continued legacy of Dalton Pharma Services in our Q1 issue.
Kevin Bottomley Drives Results
January 24, 2019
We are pleased to support Kevin Bottomley and Results Healthcare in the Q1 issue of Pharma’s Almanac.
Spotlight on Fareva Management
January 23, 2019
Pharma’s Almanac proudly supports Fareva’s management team in our Q1 issue.
Supporting KBI Biopharma
January 23, 2019
We are proud to continue supporting KBI Biopharma in our Q1 issue of Pharma’s Almanac and beyond.
Novacap Becomes Seqens
January 23, 2019
Pharma’s Almanac is excited to announce Novacap will now be named Seqens, as we share the news in our Q1 issue.
Yourway Transport in PA
January 22, 2019
Our Pharma’s Almanac strategic content team is pleased to support Yourway Transport Biopharma Services with strategic content development and placement in our Q1 DCAT issue.
Castleford Capital in PA
January 22, 2019
We look forward to supporting Jeff and the Castleford Capital team in the Q1 2019 issue of Pharma’s Almanac.
Olon S.p.A. in PA
January 22, 2019
We are pleased to support Olon S.p.A. with strategic content development and placement in the Q1 2019 'Business Issue' of Pharma's Almanac.
Supporting Asahi Kasei
January 22, 2019
That’s Nice looks forward to supporting Asahi Kasei throughout 2019.
PA Feature: WuXi Advanced Therapies
January 22, 2019
WuXi Advanced Therapies will be featured in our premiere 2019 issue of Pharma’s Almanac.
Foster Delivery Science in PA
January 22, 2019
We are pleased to support Foster Delivery Science with strategic content development and placement in the Q1 2019 edition of Pharma’s Almanac.
Supporting Emergent BioSolutions
January 21, 2019
That’s Nice looks forward to working with Emergent BioSolutions as we move through Q1 2019.
Visiting Bora Pharmaceuticals
January 18, 2019
We just wrapped a productive meeting and site tour with Bora Pharmaceuticals in Taipei and Zhunan, Taiwan. Looking forward to supporting Bora’s CDMO business with a number of strategic marketing initiatives throughout the year.
Cleanroom-Ready
January 16, 2019
That's Nice is visiting Porton Pharma Solutions’ API manufacturing site near Chongqing, China today. Pictured here is our strategy director, Mark Allen, dressed and ready to hit the cleanroom.
Team Dinner with Porton
January 15, 2019
Mark Allen (left) and Wei Gao (right) visit the striking new bridge at the center of Chongqing while meeting our friends from Porton Pharmaceutical Solutions at the famous Two Swans restaurant. We’re told they did not light up the orange especially for us.
Talking Business with Porton
January 15, 2019
Wei and Mark’s adventure in China continues today as they visit Porton Pharmaceutical Solutions' Chongqing headquarters and R&D labs.
Wishing Citoxlab Continued Success
December 28, 2018
That’s Nice would like to thank Citoxlab for the business in 2018.
Wrapping Another Year with Avara
December 28, 2018
That’s Nice would like to thank Avara Pharmaceutical Services for the business in 2018.
Driving Innovation with Formulated Solutions
December 28, 2018
That’s Nice would like to thank Formulated Solutions for the business in 2018.
Welcoming 2019 with GPH
December 28, 2018
That’s Nice wishes Gregory Pharmaceutical Holdings a prosperous 2019. We value our relationship with the GPH team and appreciate its support of That’s Nice in 2018.
Continuous Expansion at WuXi
December 28, 2018
Wuxi AppTec and its various business units have been in the media spotlight for the majority of 2018, with one press release after another announcing several global facility expansions. That’s Nice looks forward to continuing our support of WuXi across its many divisions in 2019.
Hovione Leading the Way
December 28, 2018
That’s Nice is pleased to continue our support of Hovione as the company marches forward in the spray drying space and consolidates its focus in the CDMO space moving into 2019.
Nine Years with UPM
December 28, 2018
UPM Pharmaceuticals has been a client of That’s Nice since 2010. As we move into our ninth year with the UPM team, we wish the ownership and senior staff great success in 2019.
Servier in the Holiday Spirit
December 28, 2018
Our friends at Servier’s contract development and manufacturing division have just wrapped a film-driven “26 Days of Christmas” advent calendar. Congratulations to the team and we look forward to continued success in 2019.
Looking Forward with Envigo
December 28, 2018
The global CRO Envigo has had a new name and image for the past three years. As the preclinical trials market has tightened, we look forward to supporting Envigo in 2019.
Continued Growth at Capua
December 28, 2018
Capua BioServices has experienced impressive growth over the past two years, and we look forward to continuing our support of the microbial CDMO in 2019.
Congratulating BioVectra
December 28, 2018
That’s Nice is entering our fourth year of supporting BioVectra. President Oliver Technow received the Canadian Biotech company of the year award in November. Congratulations to Oliver and the team.
Commemorating Success with GSK
December 27, 2018
That’s Nice thanks GSK for seven years of business across its various units.
AGC Leads the Way
December 27, 2018
AGC Biologics, a company That’s Nice began working with in 2012, continues to thrive. CEO Gustavo Mahler and the new management team look to lead the charge as the industry competes with Lonza and Boehringer Ingelheim on commercial projects.
Polpharma Biologics Raises the Bar
December 27, 2018
Polpharma Biologics is setting a new standard in the European mammalian biologics CDMO space. With the backing of Polpharma Group, Polpharma Biologics looks to co-develop biosimilars and innovator compounds, and also offers a full range of CDMO services from its state-of-the-art facilities.
Rentschler Establishes US Footprint
December 27, 2018
We are proud to support Rentschler Biopharma’s North American expansion with its December 2018 acquisition of the Shire manufacturing facility in Milford, Massachusetts. This family-owned business is transforming its international position in the mammalian space.
Running with Brammer Bio
December 27, 2018
That’s Nice is delighted to contribute to the success of one of the fastest growing companies in the biopharmaceutical space. Mark Bamforth, Richard Snyder and the entire Brammer Bio team are truly inspiring.
Kicking off 2019 with ACS
December 27, 2018
It was a pleasure to support the American Chemical Society in 2018, and we look forward once again to representing the Boone of the US chemicals industry in Europe.
Biotechpharma: Only Getting Better
December 27, 2018
That’s Nice looks forward to working with the senior management team at Biotechpharma as we move into the new year, with Frank Ternes recently joining as CBO and Phillip Neill as marketing director.
Soaring Stocks
December 26, 2018
That’s Nice may have been closed for Boxing Day and some electrical updates, but the stock market sure wasn’t. Let’s hope this is the turnaround we’ve been hoping for – and that it continues into 2019.
Connecting with Albemarle
December 24, 2018
It was great to connect with our old friends at Albemarle Fine Chemistry Services, a growth division of Albemarle Corporation, just before the Christmas break. That’s Nice has been working with Albemarle since the early 2000s.
Congrats on the Close
December 17, 2018
That’s Nice congratulates David Anderson and Ampersand Capital Partners on the sale of Avista, a clinical-scale small molecule, drug product and drug substance CDMO, to Cambrex.
Kicking off With Porton
December 17, 2018
That’s Nice is excited to start a new relationship with Porton Fine Chemicals, one of the few China-based CDMOs to have established a strong base of business in North America, Europe and Asia. Porton demonstrates a cross-cultural staff serving both domestic and international customers at each of their locations around the world.
Growing with Grifols
December 17, 2018
We look forward to continuing our relationship with Grifols Partnership into 2019, our fourth year supporting the Spanish giant in the sterile bag space.
Supporting HSRL
December 17, 2018
That’s Nice is pleased to be starting a new relationship with Histo-Scientific Research Laboratories (HSRL) following the company’s merger with Vet Path Services. We are proud to support another investment from Ampersand Capital Partners.